November 20, 2007 – Medical device maker Maquet said this week it will exhibit new SERVO-i product options and its Heliox therapeutic gas at the 53rd American Association for Respiratory Care conference, Dec. 1-3, 2007 in Orlando, FL.
Heliox is a therapeutic gas, which increases oxygenation of the lungs by eliminating a patient’s respiratory build-up of carbon dioxide. It will be shown by Maquet for the first time at the show. The maker says Heliox can be used on all patient categories and is compatible with all modes of ventilation. The Heliox option for SERVO-i is pending 510(k) review and is not yet commercially available in the U.S.
New NAVA (Neurally Adjusted Ventilatory Assist) technology, which lets the patient control the ventilator with his or her respiratory center in the brain, is a new approach to mechanical ventilation that will be available for demonstration in the Maquet booth. In addition, a NAVA breakfast symposium featuring Christer Sinderby, Ph.D. and Jennifer Beck, Ph.D. will be held Dec. 3.
The SERVO-i MR environment option is now commercially available in the U.S. An MR station will also be available in the booth to demonstrate how critically ill patients requiring advanced ventilatory care can remain on the same ventilator, whether they are in the ICU, MR examination room, or during transport.
For more information: www.maquet.com/us